| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/24/2023 | Arbutus Biopharma Corp | ABUS | Grant | Stock Option (Right to Buy) | 55k | $0.00 | $0 | | 05/24/2023 |
| 09/29/2022 | Immunovant, Inc. | IMVT | Purchase | Common Stock | 20k | $5.81 | $116.2k | | 09/29/2022 |
| 08/17/2022 | Immunovant, Inc. | IMVT | Grant | | 225.6k | $0.00 | $0 | | 08/17/2022 |
| 08/17/2022 | Immunovant, Inc. | IMVT | Grant | Stock Option (right to buy) | 339.3k | $4.99 | $1.7M | | 08/17/2022 |
| 05/25/2022 | Arbutus Biopharma Corp | ABUS | Grant | Stock Option (Right to Buy) | 41k | $0.00 | $0 | | 05/25/2022 |
| 01/10/2022 | Immunovant, Inc. | IMVT | Grant | | 100.1k | $0.00 | $0 | | 01/10/2022 |
| 01/10/2022 | Immunovant, Inc. | IMVT | Grant | Stock Option (right to buy) | 329.5k | $7.94 | $2.6M | | 01/10/2022 |
| 06/03/2021 | Arbutus Biopharma Corp | ABUS | Grant | Stock Options | 22k | $0.00 | $0 | | 06/03/2021 |
| 04/15/2021 | Sio Gene Therapies Inc. | AXON | Grant | Stock Option (Right to Buy) | 42k | $2.47 | $103.7k | | 04/15/2021 |
| 03/19/2021 | Immunovant, Inc. | IMVT | Grant | Common Stock | 19.2k | $0.00 | $0 | | 03/19/2021 |
| 03/19/2021 | Immunovant, Inc. | IMVT | Grant | Stock Option (right to buy) | 28.9k | $17.00 | $491.3k | | 03/19/2021 |
| 05/28/2020 | Arbutus Biopharma Corp | ABUS | Grant | Stock Options | 22k | $0.00 | $0 | | 05/28/2020 |
| 05/15/2020 | Immunovant, Inc. | IMVT | Grant | Stock Option (right to buy) | 42.6k | $19.01 | $809.8k | | 05/15/2020 |
| 05/15/2020 | Immunovant, Inc. | IMVT | Grant | Common Stock | 28.4k | $0.00 | $0 | | 05/15/2020 |
| 04/15/2020 | Sio Gene Therapies Inc. | AXON | Grant | Stock Option (Right to Buy) | 17.5k | $3.45 | $60.4k | | 04/15/2020 |
| 12/18/2019 | Immunovant, Inc. | IMVT | Grant | Stock Option (right to buy) | 3.8k | $8.43 | $31.7k | | 12/18/2019 |
| 12/18/2019 | Immunovant, Inc. | IMVT | Grant | Stock Option (right to buy) | 11.5k | $8.43 | $96.8k | | 12/18/2019 |
| 12/18/2019 | Immunovant, Inc. | IMVT | Grant | Stock Option (right to buy) | 893 | $7.86 | $7k | | 12/18/2019 |
| 12/18/2019 | Immunovant, Inc. | IMVT | Grant | Stock Option (right to buy) | 137.6k | $7.86 | $1.1M | | 12/18/2019 |
| 08/23/2019 | Myovant Sciences Ltd. | MYOV | Grant | Stock Option (Right to Buy) | 58.6k | $7.65 | $448.4k | | 08/23/2019 |
| 08/17/2019 | Arbutus Biopharma Corp | ABUS | Grant | Stock Options | 22k | $0.00 | $0 | | 08/17/2019 |
| 07/09/2019 | Urovant Sciences Ltd. | UROV | Grant | Stock Option (Right to Buy) | 25k | $8.78 | $219.5k | | 07/09/2019 |
| 04/15/2019 | Sio Gene Therapies Inc. | AXON | Grant | Stock Option ( Right to Buy) | 255k | $1.06 | $270.3k | | 04/15/2019 |
| 11/26/2018 | Arbutus Biopharma Corp | ABUS | Grant | Director Share Option (right to buy) | 44k | $4.72 | $207.7k | | 11/26/2018 |
| 11/21/2018 | Urovant Sciences Ltd. | UROV | Grant | Stock Option (Right to Buy) | 50k | $8.01 | $400.5k | | 11/21/2018 |
| 11/06/2018 | Myovant Sciences Ltd. | MYOV | Grant | Stock Option (Right to Buy) | 45k | $22.83 | $1M | | 11/06/2018 |
| 10/15/2018 | Sio Gene Therapies Inc. | AXON | Grant | Stock Option ( Right to Buy) | 150k | $2.37 | $355.5k | | 10/15/2018 |